PharmacyCodes



Nitrofuradantin en es it fr

Categorie

Nitrofuradantin Les marques, Nitrofuradantin Analogs

Nitrofuradantin Les marques melange

  • No information avaliable

    • Nitrofuradantin Formule chimique

    C8H6N4O5

    Nitrofuradantin RX lien

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Nitrofuradantin FDA fiche

    Nitrofuradantin msds (fiche de securite des materiaux)

    Nitrofuradantin MSDS

    Nitrofuradantin Synthese de reference

    Aucune information disponible

    Nitrofuradantin Poids moleculaire

    238.157 g/mol

    Nitrofuradantin Point de fusion

    263 oC

    Nitrofuradantin H2O Solubilite

    79,5 mg / L

    Nitrofuradantin Etat

    Solid

    Nitrofuradantin LogP

    -0.04

    Nitrofuradantin Formes pharmaceutiques

    Tablet

    Nitrofuradantin Indication

    Pour le traitement de l'infection des voies urinaires

    Nitrofuradantin Pharmacologie

    Nitrofurantoin, un nitrofurane agent antibactérien, est disponible sous forme microcristalline et macrocristallin pour traiter les infections des voies urinaires causées par de nombreuses bactéries gram-négatives et certaines bactéries Gram-positives.

    Nitrofuradantin Absorption

    Aucune information disponible

    Nitrofuradantin Toxicite

    Aucune information disponible

    Nitrofuradantin Information pour les patients

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Nitrofuradantin Organismes affectes

    Gram négatif et certaines bactéries Gram positives